People: Zurich Insurance Group AG (ZURN.VX)

ZURN.VX on Virt-X Level 1

309.10CHF
19 Dec 2014
Price Change (% chg)

CHF4.60 (+1.51%)
Prev Close
CHF304.50
Open
CHF306.80
Day's High
CHF309.80
Day's Low
CHF304.50
Volume
1,250,901
Avg. Vol
546,596
52-wk High
CHF309.80
52-wk Low
CHF244.20

Search Stocks

de Swaan, Tom 

Brief Biography

Dr. Tom de Swaan has been appointed Chairman of the Board of Zurich Insurance Group AG effective September 2013. He is Chairperson of the Governance and Nominations Committee, Member of the Remuneration Committee. Prior to that, he served as Acting Chairman of the Board at Zurich Insurance Group AG effective August 29, 2013. Prior to that, he was Non-Executive Member of the Board of Directors of Zurich Insurance Group AG since April 20, 2006. He is Member of the Board of Directors and Chairman of the Audit Committee of Zurich Insurance plc. He joined De Nederlandsche Bank N.V., in 1972, and, from 1986 until 1998, has served as Member of the Governing Board. In January 1999, he became Member of the Managing Board and Chief Financial Officer of ABN AMRO Bank. He retired from ABN AMRO, on May 1, 2006, but continued as Adviser to the Managing Board until June 2007. Dr. de Swaan is Non-Executive Member of the Board of GlaxoSmithKline Plc and Chairman of its Audit Committee. He is Member of the Supervisory Board of Royal DSM. Since May 10, 2008, he is Chairman of the Supervisory Board of Van Lanschot NV. From 1987 to 1988, he has served as Chairman of the Amsterdam Financial Center and, from 1995 to 1997, Chairman of the Banking Supervisory Sub-Committee of the European Monetary Institute. He was also Member of the Basel Committee on Banking Supervision, from 1991 to 1996, its Chairman, from 1997 to 1998, and Non-Executive Director on the Board of the United Kingdom’s Financial Services Authority from January 2001 until the end of 2006. Dr. de Swaan is also Director of a number of non-profit organizations. Among others, he is Treasurer of the Board of the Royal Concertgebouw Orchestra, the Netherlands Cancer Institute and the International Franz Liszt Piano Competition. Moreover, he chairs the Advisory Board of the Rotterdam School of Management. Dr. de Swaan graduated from the Universiteit van Amsterdam with a Masters degree in Economics.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
589,041 -- 80,000 669,041

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tom de Swaan

669,041

Martin Senn

7,600,000

Fred Kindle

316,082

George Quinn

--

Robert Dickie

--

Cecilia Reyes

--
As Of 30 Dec 2013
Search Stocks